Gene · 11274
Papers1,718
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,718
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP18 promotes cell proliferation and inhibits ferroptosis by stabilizing HDAC3 in endometrial carcinoma. | Exp Cell Res | 2026 | 41547495 | PubTator, text mining | PubMed |
| HIV-1 derived oligonucleotides induce a type I IFN/STING dependent immune suppression reversible by targeting IFNARI. | PLoS Pathog | 2026 | 41529066 | PubTator, text mining | PubMed |
| USP18 promotes nasopharyngeal carcinoma radioresistance via TRIM29 oligomerization and ubiquitination. | Cell Death Differ | 2026 | 41219493 | PubTator, text mining | PubMed |
| Ubiquitin choreography in nasopharyngeal carcinoma: USP18 scaffolds radioresistance. | Cell Death Differ | 2026 | 41219492 | PubTator, text mining | PubMed |
| USP18 gene mutation associated with recurrent encephalopathy, intracranial calcification, and microcephaly: case report, long-term follow-up, and literature review. | Clin Dysmorphol | 2026 | 41198138 | PubTator, text mining | PubMed |
| Novel molecular biomarkers in kidney diseases: bridging the gap between early detection and clinical implementation. | J Pharm Pharmacol | 2026 | 41100213 | PubTator, text mining | PubMed |
| Long non-coding RNAs in response to Ebola virus vaccine-induced immunity. | Front Immunol | 2025 | 41744005 | PubTator, text mining | PubMed |
| The evolving mpox threat (2022-2024): clade dynamics, immune evasion, and escalating global health challenges. | Front Cell Infect Microbiol | 2025 | 41737841 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| USP18 promote tumor immune evasion in pancreatic cancer through enhancing autolysosome-mediated degradation of MHC-I. | Am J Cancer Res | 2025 | 41395285 | PubTator, text mining | PubMed |
| Immune transcriptomic differences in paediatric patients with SARS-CoV-2 compared to other lower respiratory tract infections. | bioRxiv | 2025 | 41279033 | PubTator, text mining | PubMed |
| USP18 inhibits CVB3-induced pyroptosis and fibrosis of mouse cardiomyocytes through the IRF7/NF-κB signaling pathway. | Mol Immunol | 2025 | 41205480 | PubTator, text mining | PubMed |
| Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus. | Nat Commun | 2025 | 41038828 | PubTator, text mining | PubMed |
| Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance. | bioRxiv | 2025 | 41000885 | PubTator, text mining | PubMed |
| Inhibition of USP18 in the presence of IFN-α elevates apoptosis, autophagy, and chemosensitivity of oesophageal cancer cell lines. | Exp Cell Res | 2025 | 40998229 | PubTator, text mining | PubMed |
| Novel USP18 mutations lead to severe interferonopathy responsive to JAK inhibitor. | Front Immunol | 2025 | 40977694 | PubTator, text mining | PubMed |
| De novo pathogenic CSF1R variant implicates microglial dysfunction in pathogenesis of febrile infection-related epilepsy syndrome. | Epilepsia | 2025 | 40956030 | PubTator, text mining | PubMed |
| Genetic background of neurological disorders with basal ganglia calcification. | J Neurol | 2025 | 40947452 | PubTator, text mining | PubMed |
| USP18 Deficiency Presenting as Severe Neonatal Encephalopathy: A Case Report and Review of Pseudo-TORCH Syndromes. | Cureus | 2025 | 40937018 | PubTator, text mining | PubMed |
| Enhanced ISGylation via USP18 Isopeptidase Inactivation Fails to Mitigate the Inflammatory or Functional Course of Coxsackievirus B3-Induced Myocarditis. | Cell Physiol Biochem | 2025 | 40926642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11274/papers?page=4